ipulse limited

Live EstablishedLargeDeclining

ipulse limited Company Information

Share IPULSE LIMITED

Company Number

08306196

Directors

Robert Clement

Nigel Rudd

View All

Shareholders

richard koch

mainspring nominees limited

View All

Group Structure

View All

Industry

Manufacture of medical and dental instruments and supplies

 

Registered Address

office block a, bay studios business park, swansea, SA1 8QB

ipulse limited Estimated Valuation

£121.7m

Pomanda estimates the enterprise value of IPULSE LIMITED at £121.7m based on a Turnover of £83.8m and 1.45x industry multiple (adjusted for size and gross margin).

ipulse limited Estimated Valuation

£12.4m

Pomanda estimates the enterprise value of IPULSE LIMITED at £12.4m based on an EBITDA of £1.5m and a 8.31x industry multiple (adjusted for size and gross margin).

ipulse limited Estimated Valuation

£49m

Pomanda estimates the enterprise value of IPULSE LIMITED at £49m based on Net Assets of £21.9m and 2.23x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Ipulse Limited Overview

Ipulse Limited is a live company located in swansea, SA1 8QB with a Companies House number of 08306196. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in November 2012, it's largest shareholder is richard koch with a 65.8% stake. Ipulse Limited is a established, large sized company, Pomanda has estimated its turnover at £83.8m with declining growth in recent years.

View Sample
View Sample
View Sample

Ipulse Limited Health Check

Pomanda's financial health check has awarded Ipulse Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4out of 5
positive_score

5 Strong

positive_score

3 Regular

positive_score

4 Weak

size

Size

annual sales of £83.8m, make it larger than the average company (£17.8m)

£83.8m - Ipulse Limited

£17.8m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -4%, show it is growing at a slower rate (6.2%)

-4% - Ipulse Limited

6.2% - Industry AVG

production

Production

with a gross margin of 14.8%, this company has a higher cost of product (37.4%)

14.8% - Ipulse Limited

37.4% - Industry AVG

profitability

Profitability

an operating margin of -2.3% make it less profitable than the average company (6%)

-2.3% - Ipulse Limited

6% - Industry AVG

employees

Employees

with 275 employees, this is above the industry average (90)

275 - Ipulse Limited

90 - Industry AVG

paystructure

Pay Structure

on an average salary of £38.9k, the company has a lower pay structure (£49.5k)

£38.9k - Ipulse Limited

£49.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £304.7k, this is more efficient (£179.4k)

£304.7k - Ipulse Limited

£179.4k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 46 days, this is near the average (50 days)

46 days - Ipulse Limited

50 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 56 days, this is slower than average (35 days)

56 days - Ipulse Limited

35 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 88 days, this is in line with average (95 days)

88 days - Ipulse Limited

95 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (11 weeks)

1 weeks - Ipulse Limited

11 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 45.8%, this is a similar level of debt than the average (41.9%)

45.8% - Ipulse Limited

41.9% - Industry AVG

IPULSE LIMITED financials

EXPORTms excel logo

Ipulse Limited's latest turnover from December 2023 is £83.8 million and the company has net assets of £21.9 million. According to their latest financial statements, Ipulse Limited has 275 employees and maintains cash reserves of £634 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013
Turnover83,795,690100,461,160101,401,26894,105,89848,418,66027,392,61932,873,63617,492,1115,603,8875,916,3443,409,418
Other Income Or Grants
Cost Of Sales71,359,79688,479,37685,554,94271,958,03736,803,35821,958,41426,135,69814,705,1833,204,6433,841,1592,323,272
Gross Profit12,435,89411,981,78415,846,32622,147,86111,615,3025,434,2056,737,9382,786,9282,399,2442,075,1851,086,146
Admin Expenses14,330,48212,935,98012,198,3129,086,8954,523,0663,247,7772,725,3272,124,6313,334,5053,192,3902,589,794
Operating Profit-1,894,588-954,1963,648,01413,060,9667,092,2362,186,4284,012,611662,297-935,261-1,117,205-1,503,648
Interest Payable536,207211,983126,181124,26087,69559,404202,880136,95088,913120,1928,093
Interest Receivable6301,24780622,3601,4875681918264,12373,157
Pre-Tax Profit-2,430,165-1,164,9323,521,91312,936,7687,006,9012,128,5113,810,299525,538-1,023,348-1,233,274-1,438,584
Tax55,529429,124-408,430198,2601,333,747-41,255-13,48474,283212,631173,754236,493
Profit After Tax-2,374,636-735,8083,113,48313,135,0288,340,6482,087,2563,796,815599,821-810,717-1,059,520-1,202,091
Dividends Paid4,854,019
Retained Profit-2,374,636-735,8083,113,4838,281,0098,340,6482,087,2563,796,815599,821-810,717-1,059,520-1,202,091
Employee Costs10,684,00310,164,0069,809,9066,052,2783,770,3133,164,5562,574,1201,833,1321,576,5101,119,6111,116,626
Number Of Employees275280252183104513932302624
EBITDA*1,494,3882,207,2696,295,44714,491,9507,813,9052,707,1004,361,448987,300-593,434-722,432-1,182,465

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013
Tangible Assets6,275,3728,256,0218,797,3237,320,4892,044,5221,232,613511,906463,563428,419306,105242,237
Intangible Assets1,609,0171,635,2051,511,4041,248,186630,050559,312524,751565,288453,394313,593521,087
Investments & Other
Debtors (Due After 1 year)14,3995,418
Total Fixed Assets7,898,7889,896,64410,308,7278,568,6752,674,5721,791,9251,036,6571,028,851881,813619,698763,324
Stock & work in progress17,293,35018,261,08623,896,30616,782,8079,631,9685,248,1501,005,150316,077434,526369,903827,948
Trade Debtors10,749,8198,719,6187,678,2498,002,3434,333,3764,966,5863,664,4383,646,5171,795,7501,127,8691,498,374
Group Debtors
Misc Debtors3,875,1414,397,0344,551,9285,430,3032,306,828813,5511,264,270553,479768,072406,081345,497
Cash633,9781,649,3612,879,3161,146,6951,884,6272,890,3844,072,6201,577,6381,046,0721,645,4621,751,631
misc current assets
total current assets32,552,28833,027,09939,005,79931,362,14818,156,79913,918,67110,006,4786,093,7114,044,4203,549,3154,423,450
total assets40,451,07642,923,74349,314,52639,930,82320,831,37115,710,59611,043,1357,122,5624,926,2334,169,0135,186,774
Bank overdraft317,00019,000
Bank loan214,2603,857,035841,07274,408400,000400,0005,66617,000
Trade Creditors 11,123,77910,904,38810,966,23713,030,6245,181,8097,248,7313,800,0513,414,7942,405,489972,5011,081,006
Group/Directors Accounts
other short term finances
hp & lease commitments4,7357,104
other current liabilities5,411,3025,230,5186,718,1523,506,2271,043,7861,040,1031,631,8872,138,3381,905,822627,695613,356
total current liabilities16,535,08116,349,16621,546,15917,385,0276,300,0038,688,8345,831,9385,558,7984,328,3141,617,1961,713,362
loans841,07633,317466,6515,66622,66739,666
hp & lease commitments4,143
Accruals and Deferred Income1,158,9631,809,4672,247,436677,821
other liabilities1,395,9091,388,637
provisions810,541559,548755,613245,672452,148756,4811,068,988755,519525,892365,206306,154
total long term liabilities1,969,5042,369,0153,003,0491,768,712452,148789,7981,535,639755,519531,5581,783,7821,734,457
total liabilities18,504,58518,718,18124,549,20819,153,7396,752,1519,478,6327,367,5776,314,3174,859,8723,400,9783,447,819
net assets21,946,49124,205,56224,765,31820,777,08414,079,2206,231,9643,675,558808,24566,361768,0351,738,955
total shareholders funds21,946,49124,205,56224,765,31820,777,08414,079,2206,231,9643,675,558808,24566,361768,0351,738,955
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013
Operating Activities
Operating Profit-1,894,588-954,1963,648,01413,060,9667,092,2362,186,4284,012,611662,297-935,261-1,117,205-1,503,648
Depreciation2,793,0152,676,7992,217,2571,142,198490,911296,665167,002155,154158,010107,740131,663
Amortisation595,961484,666430,176288,786230,758224,007181,835169,849183,817287,033189,520
Tax55,529429,124-408,430198,2601,333,747-41,255-13,48474,283212,631173,754236,493
Stock-967,736-5,635,2207,113,4997,150,8394,383,8184,243,000689,073-118,44964,623-458,045827,948
Debtors1,517,289891,893-1,202,4696,792,442860,067851,429728,7121,636,1741,029,872-309,9211,843,871
Creditors219,391-61,849-2,064,3877,848,815-2,066,9223,448,680385,2571,009,3051,432,988-108,5051,081,006
Accruals and Deferred Income-469,720-1,925,6034,781,5403,140,2623,683-591,784-506,451232,5161,278,12714,339613,356
Deferred Taxes & Provisions250,993-196,065509,941-206,476-304,333-312,507313,469229,627160,68659,052306,154
Cash flow from operations1,001,0285,196,2033,203,08111,529,5301,536,195115,8053,122,4541,015,3061,396,503184,174-1,617,275
Investing Activities
capital expenditure-356,643-472,041-603,942-251,147-1,084,507
Change in Investments
cash flow from investments-356,643-472,041-603,942-251,147-1,084,507
Financing Activities
Bank loans-214,260-3,642,7753,015,963766,664-325,592394,334-11,33417,000
Group/Directors Accounts
Other Short Term Loans
Long term loans-841,076841,076-33,317-433,334466,651-5,666-17,001-16,99939,666
Hire Purchase and Lease Commitments-4,735-6,51211,247
other long term liabilities-1,395,9097,2721,388,637
share issue115,565176,052874,751-1,583,145-493,392469,150-929,502142,063109,04388,6002,941,046
interest-535,577-210,736-126,101-124,198-85,335-57,917-202,312-136,759-88,087-116,06965,064
cash flow from financing-634,272-3,682,1942,917,025-88,356-937,636-22,101-270,829-11,696-1,374,954-37,1964,434,413
cash and cash equivalents
cash-1,015,383-1,229,9551,732,621-737,932-1,005,757-1,182,2362,494,982531,566-599,390-106,1691,751,631
overdraft-3-16,997-2,00019,000
change in cash-1,015,383-1,229,9551,732,621-737,932-1,005,757-1,182,2362,494,982531,569-582,393-104,1691,732,631

ipulse limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for ipulse limited. Get real-time insights into ipulse limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Ipulse Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for ipulse limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in SA1 area or any other competitors across 12 key performance metrics.

ipulse limited Ownership

IPULSE LIMITED group structure

Ipulse Limited has 2 subsidiary companies.

Ultimate parent company

IPULSE LIMITED

08306196

2 subsidiaries

IPULSE LIMITED Shareholders

richard koch 65.76%
mainspring nominees limited 14.59%
bury fitzwilliam-lay & partners 4.54%
nigel russell rudd 2.43%
cigp asset management ltd 2.24%
coleman investments ltd 1.8%
woodbourne nominees 1.57%
alice mary cleoniki avis 1.16%
employee benefit trust (ebt) 1.01%
lesley rudd 0.81%

ipulse limited directors

Ipulse Limited currently has 6 directors. The longest serving directors include Prof Robert Clement (Sep 2013) and Sir Nigel Rudd (Sep 2013).

officercountryagestartendrole
Prof Robert ClementUnited Kingdom71 years Sep 2013- Director
Sir Nigel RuddUnited Kingdom78 years Sep 2013- Director
Ms Alice AvisScotland62 years Sep 2013- Director
Mr Jamie Reeve60 years Nov 2017- Director
Mr Thomas BeckettEngland63 years Apr 2019- Director
Mr Robin Van Rozen50 years Feb 2023- Director

P&L

December 2023

turnover

83.8m

-17%

operating profit

-1.9m

+99%

gross margin

14.9%

+24.43%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

21.9m

-0.09%

total assets

40.5m

-0.06%

cash

634k

-0.62%

net assets

Total assets minus all liabilities

ipulse limited company details

company number

08306196

Type

Private limited with Share Capital

industry

32500 - Manufacture of medical and dental instruments and supplies

incorporation date

November 2012

age

13

incorporated

UK

ultimate parent company

None

accounts

Group

last accounts submitted

December 2023

previous names

mc 500 limited (December 2012)

accountant

-

auditor

BEVAN BUCKLAND LLP

address

office block a, bay studios business park, swansea, SA1 8QB

Bank

-

Legal Advisor

-

ipulse limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to ipulse limited.

ipulse limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for IPULSE LIMITED. This can take several minutes, an email will notify you when this has completed.

ipulse limited Companies House Filings - See Documents

datedescriptionview/download